Rules Navigator

Sign in
Register

HHS agency signals drug rebate program redux with request for information

Pill bottles
Photo: George Frey/Getty Images

Kevin Kinsella

3 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

The RFI is the Trump administration’s next move to get its drug pricing rebate program back on track after hospital groups blocked it last year.

The Health Resources and Services Administration (HRSA) has issued a request for information (RFI) for input related to the use of rebates to establish the ceiling price of drugs in the federal 340B program.

Through the RFI, HRSA also seeks to establish the “standards and procedures that should govern the

Register for free to keep reading

To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.

  • Unlimited access to industry insights
  • Stay on top of key rules and regulatory changes with our Rules Navigator
  • Ad-free experience with no distractions
  • Regular podcasts from trusted external experts
  • Fresh compliance and regulatory content every day
Register for free
Sign in
, , , , , , , , , ,